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Determinants of Early Life Leptin Levels 
and Later Life Degenerative Outcomes
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The early (intrauterine and neonatal) life environment plays an important role in programming the
susceptibility in later life to chronic degenerative diseases, such as obesity, cardiovascular diseases,
diabetes mellitus, cancer and osteoporosis.Among other hormones, leptin plays a major role in the
regulation of the overall metabolism and has multiple neuroendocrine (adeno- and neuro-hypophysis
axes and the hypothalamus–pituitary–adrenal axis) and immune functions.The hormone exerts its
actions beginning in the early life time period, regulating the intrauterine and early extrauterine life
growth and development, as well as the adaptation to extrauterine life, neonatal thermogenesis and
response to stress. Recent findings also support a role of leptin in the process of fetal bone
remodeling and brain development.Therefore, it is of interest to explore the physiology of leptin
in early life, as well as those factors that may perturb the balance of the hormone with pathological
consequences in terms of confining an increased risk for disease in later life.This review aims to
summarize reported findings concerning the role of leptin in early life, as well as the association of
fetal, maternal and placental factors with leptin levels, while attempting to speculate mechanisms
through which these factors may influence the risk for developing chronic diseases in later life.
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Intrauterine factors are important determinants of weight at
birth, whereas a poor intrauterine milieu may program an
increased susceptibility and, eventually, risk for developing
chronic degenerative diseases in later life, such as obesity,
hypertension, other cardiovascular diseases, type-2 diabetes
mellitus and osteoporosis.1-6 With regards to carcinogenesis, in
particular breast cancer, the association of fetal hormone levels
with the stem cell potential has pointed to the early life roots of
the disease in the sense that a highly estrogenic intrauterine
environment may represent a ‘fertile soil’ for carcinogenesis in
the breast tissue.7 Apart from pregnancy estrogens, there has
been an increasing interest in exploring the potential role of
other components of the intrauterine and infantile hormonal
environment in the causation of chronic diseases in later life,
and leptin is a strong candidate among them.
Leptin, the product of the obesity (ob) gene, was discovered
relatively recently (1994) and is a hormone of 16 kDa
comprising 167 amino acids.8 The central source of leptin is
the adipose tissue (white and brown), although it can be also
produced in other sites, including the placenta.9
Leptin plays an essential role in the regulation of energy
homeostasis, food intake and body composition beginning in
the early life, when the hormone also controls overall fetal
growth and development.9 At the central nervous system
(CNS) level, leptin exerts neurotrophic actions that control
feeding during the critical period of development of the
hypothalamus. Unlike what happens in later life, some
findings from animal studies indicate that leptin does not
inhibit the appetite during intrauterine and early postnatal
life. On the contrary, it seems that leptin promotes
swallowing activity and hyperphagia, therefore contributing
to the rapid growth and weight gain of the newborn, but this
evidence is still inconclusive.10,11 Thus, factors that
influence fetal leptin levels may alter the programming of the
appetite behavior by modifying the normal set-points, as well
as the energy metabolism and adiposity. These changes
further lead to an increased risk of developing cardiovascular
and metabolic diseases in later life.10,12,13
Children suffering from leptin deficiency due to a rare leptin
gene mutation develop morbid obesity in early childhood,
have no pubertal development and have important
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dysfunctions of growth and thyroid hormones.14 Neonates
that have either high leptin levels at birth (e.g., offspring of
mothers with gestational diabetes)15,16 or low leptin levels
(e.g., small for gestational age infants)17 have a higher risk of
developing obesity and type 2 diabetes mellitus compared
with children who have normal leptin levels at birth.18
Furthermore, some evidence from experimental studies
supports the involvement of leptin in the formation of
mammary glands, whereas both physiological and
pathological breast cells express leptin.19-21 Therefore, an
adverse intrauterine environment that modifies leptin levels
may perturb the reproductive path and increase the risk of
breast cancer in adult life. Lastly, there is accumulating
evidence that the risk of osteoporosis may also be determined
by factors acting on the bone development during the
intrauterine and infant life via the alterations in leptin
dynamics.22,23
Given the importance of fetal adipose tissue and its
hormones, including leptin, in terms of fetal growth and
maturation for both survival at birth and overall health, we
present a review of published evidence related to the role of
leptin in early life physiology, specifically in relation to the
reproductive function overall, energy homeostasis, infant
growth, brain development and fetal bone remodeling.
Moreover, an effort is made to summarize reports on the
influence of fetal, maternal and placental factors in defining
leptin levels with special focus on how these variables may
affect the pathological risk in later life.
MULTIPLE ROLES OF LEPTIN IN HUMAN
PHYSIOLOGY
Leptin in Relation to Energy Homeostasis
In adults, leptin regulates overall metabolism, including food
intake, energy balance and body temperature by signaling
satiety and decreasing the sensation of hunger at the
hypothalamic level.24 At the peripheral level, the hormone
stimulates the process of oxidation of fatty acids in muscles,
inhibits the accumulation of triglycerides in hepatic cells,25
and has potent lipid-lowering effects in peripheral tissues and
plasma that are thought to be essential for the prevention of
cellular lipotoxicity and insulin resistance.26
Basic functions of the organism, such as thirst and 
hunger-mediated ingestive behavior, are programmed in utero,
and leptin seems to be an essential regulator in this process
through its neurotrophic actions at the hypothalamic
level.10,12,13 There is some evidence from experimental studies,
however debatable, that in early neonatal life, leptin may
promote hyperphagia as an adaptive response to overcome the
physiological weight loss observed during postnatal days10,11
and may also be a signal that initiates the enteric feeding.26 The
full extent of the involvement of this hormone in the regulation
of these functions, however, has not been clarified.
Leptin in Relation to Growth and Development of
the Fetus and the Infant
Different growth patterns in utero are accompanied by
specific changes in leptin levels.27 For instance, small for
gestational age infants have lower leptin levels at birth than
appropriate for gestational age children. On the contrary,
large for gestational age neonates have higher leptin
levels.17,18 Thus, leptin may be an important factor for growth
and development of the fetus, whereas its effects seem
independent of insulin and the growth hormone insulin-like
growth factor-I system.9
Recent studies suggest the implication of leptin in the
regulation of some mitochondrial proteins, such as the
uncoupling protein-1, specific to brown adipose tissue and
critically important for the initiation of non-shivering
thermogenesis of the newborn and during the transition from
fetal to neonatal life.26,28
Leptin in Relation to Reproductive Function
Leptin seems to be the physiological link between 
nutritional status and reproductive maturation, interfering
with the regulation of adeno- and neuro-hypophysis (growth
hormone, hypothalamo-pituitary-thyroid-axis, and
hypothalamo-pituitary-adrenal and gonadal axes).14,25,29,30 It
provides the CNS with information regarding the critical
amount of adipose tissue and regulates the reproductive function
at the central level via the gonadotropin-releasing hormone and
hypothalamic-pituitary-gonadal axis, respectively.29,30
Furthermore, it has been shown that the secretion of leptin has
a pulsatile rhythm, synchronized with that of the luteinizing
hormone and estradiol.30 Therefore, normal leptin levels are
important prerequisites for both the onset of puberty and the
maintenance of menstrual cycles and normal reproductive
function.31-35
Leptin in Relation to Stress
In animal studies, leptin was found to inhibit responses to
stress through enhancement of glucocorticoid receptor
expression in CNS and sensitization of the glucocorticoid
inhibitory feedback.36,37 These mechanisms are already
present at birth and provide the newborn with a regulatory
mechanism against the variation of adrenal hormones during
the critical period of brain development.36,38 The role of
leptin in human adrenal axis remains controversial, however.
While some observational studies reported an inverse
association between leptin and adrenocorticotropic hormone
levels, other studies comprising subjects with mutations in
leptin or the leptin receptor gene reported a normal adrenal
function in these people.39
Leptin in Relation to Brain Development and
Psychiatric Outcomes
The question whether leptin has direct involvement in the
development of the brain has been explored in some
experimental studies. Leptin is thought to be related to brain
development, because leptin receptors are widely expressed
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in the brain and because brain weight as well as brain protein
and DNA contents are reduced in adult leptin deficient mice
(ob/ob).40 This observation, however, has not been confirmed
in the few studies of leptin deficiency in humans.9 Another
interesting finding of a recent report indicates a possible
action of leptin as a cognitive enhancer in the hippocampus
and on excitatory synaptic strength.41
There is some clinical evidence among adults suffering from
major psychiatric diseases that the balance of leptin is
disturbed.42 It is not clear, however, whether these changes in
leptin levels reflect the modification of appetite behavior
associated with these disorders or an involvement of leptin in
the etiologic pathway of these conditions.
Leptin and Fetal Bone Remodeling
Leptin controls fetal bone remodeling by enhancing the
differentiation of human bone marrow stromal cells to
osteoblasts and decreasing bone resorption.43-45 Along with
the gradual increase in fetal leptin levels with the
advancement of gestation, a significant inverse correlation
between leptin and the markers of bone resorption has been
reported.43 It has been proposed that leptin might act, via
sympathetic signaling, to modulate the proliferation of
osteoblasts, but the exact mechanism of leptin action on bone
formation has not been elucidated.45
Other findings from animal studies show a positive
association between early postnatal leptin levels in piglets and
bone mass, along with a negative correlation between leptin
and osteocalcine, a peptide that reflects the activity of
osteoblasts.46 Furthermore, in young ob/ob mice who lack
leptin, an elevation of bone size, bone density and mineral
content following treatment with leptin has been reported.47-49
These findings, namely a strong association between leptin
concentrations, body bone mineral contents and estimated
bone density, have been recently confirmed in a study
including human neonates.23
Further studies are needed, however, to explore the function,
site and mode of action of leptin on bone formation given the
important implications of such a relation. If a direct link
between leptin and intrauterine bone formation is clearly
demonstrated, it may imply that the risk of osteoporosis in
later life may be determined in early life through the
regulatory mechanism of leptin,23 indicating that
interventions for prevention of osteoporosis should start in
early life.
Other Roles of Leptin
Leptin promotes hematopoiesis and lymphopoiesis,
stimulating the proliferation and differentiation of yolk sac
cells, fetal liver cells and hematopoietic precursors.50-52
However, the exact pathways and mechanisms have not yet
been determined. At the intestinal level, leptin is implicated in
the maturation of intestinal mucosa in the early stages of life
and seems to have a protective effect against cell apoptosis
and autophagy in the neonatal gut epithelium.53 Finally, some
animal studies indicate that leptin seems to contribute to
pulmonary development in utero, as both the hormone and its
receptor are expressed by fibroblasts and pulmonary
epithelial cells, including fetal lung type II cells responsible
for the secretion of pulmonary surfactant.54,55
SYNTHESIS AND DYNAMICS OF LEPTIN
DURING PREGNANCY
Leptin seems to be a critical factor for overall fetal
development, as well as the evolution and maintenance of the
pregnancy, while the regulation and the dynamics of the
secretion of the hormone during pregnancy are extremely
complex processes. The hormone is produced in both
maternal and fetal adipose tissues and in the placenta, while
its receptors are expressed in the uterine endometrium and
trophoblast and the fetus.56
Maternal Leptin Levels
Circulating maternal leptin levels are substantially elevated
during pregnancy due to the gradual increase of the body
mass index throughout gestation, whereas the placenta seems
to be an independent source of leptin.57,58 Increased levels of
estradiol stimulate leptin production from adipocytes. The
elevated cortisol and insulin levels during pregnancy seem to
be involved in this process as well.33
The dynamics of leptin follow the overall major metabolic
changes during the gestational period, including the anabolic
to catabolic shift, and provide further support that leptin is
one of the essential factors regulating maternal and fetal
energy balance.9,57 A two-fold increase in leptin levels is
observed in mid-pregnancy, which corresponds to the
enhancement of bound leptin levels.57 During labor, another
significant increase of leptin levels is encountered, which is
more pronounced in vaginal compared to Caesarean section
delivery. Eventually, maternal leptin levels reach those of a
physiological non-pregnant woman 3 to 6 days after delivery.57,59
Fetal Leptin Levels
Fetal adipose tissue is an important source of leptin. Leptin has
been identified in fat biopsies obtained from fetuses that died
in utero between the 20th and 38th gestational week.60 However,
the production of the hormone seems to start earlier with
lipidogenesis itself, as shown by immunocytochemical staining
of developing subcutaneous tissues of human embryos at 6 to
10 weeks of gestation.61 Leptin is produced primarily by white
adipose tissue cells, while there is some evidence that brown
adipose tissue is another source of fetal leptin.26
The dynamics of fetal leptin levels follow the evolution of
fetal adipose tissue. Thus, the limited development of fetal
adipose cells prior to the ages of 32 to 34 weeks is followed
by a significant increase of the adipose mass.62,63 Similarly,
the low fetal leptin levels during the first half of gestation
increase dramatically during the last part of the third
trimester.63,64 The nonsignificant correlation between leptin
levels, measured in fetal cord blood between the age of 14 to
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32 weeks, and the pattern of growth emphasizes the
importance of the development of adipose tissue in defining
leptin levels.64 Similar findings were reported in animal
studies in which leptin was detected in fetal adipose tissue by
the end of the second trimester with a significant increase up
to term.26
Placental Leptin Levels
Human placenta expresses the ob gene, and syncytiotrophoblasts
have been shown to synthesize leptin.28,65 Most of the
placental produced leptin is released into maternal circulation
and only a small percent is released to the fetus.66 The sharp
decline in maternal leptin levels following delivery or a
spontaneous abortion may, in fact, reflect the cessation of the
placental function.57,59 Several investigators have emphasized
the contribution of the placenta as an additional source of
fetal leptin.26 In support of this theory is the positive
correlation between placental and umbilical cord leptin
levels, along with the independence noted between maternal
and infant leptin levels.28,67
Umbilical Vein and Umbilical Artery Leptin Levels
Throughout gestation, leptin concentrations are higher in the
umbilical vein compared to those in the umbilical artery, and
the difference increases significantly during the second half of
pregnancy.68 The difference persists at delivery, whereas a
sharp decline in the leptin levels is observed on the 5th
postnatal day.69 Notably, umbilical artery leptin seems to have
a closer relationship to neonatal anthropometry, while
umbilical vein leptin is more closely related to maternal
characteristics.70 In vaginal deliveries, leptin concentrations in
both the umbilical artery and the umbilical vein are increased
compared to those in Caesarean sections, indicating an
augmented placental leptin release during advanced labor.71
FACTORS AFFECTING LEPTIN LEVELS AFTER
DELIVERY
Neonatal Leptin Levels
Two to three times higher serum leptin levels are observed
among infants compared to those among adults.72 The origin
of newborn leptin from three different sources, the increased
adipose leptin mRNA expression in fetal adipose tissue, and
the onset of synthesis of leptin prior to the maturation of its
receptor may explain this difference.73
Sociodemographic Factors
● Gender. At birth, female newborns have consistently
been found to have higher leptin levels than males.74-87
Underlying causes might be the differential amount of
fat tissue by gender, the role of the variable sex steroid
milieus of the newborn and the heavier placental
weight associated with female gender.72,88
● Family history of obesity. Among other determinants 
of newborn leptin levels, is that family history of
obesity on the paternal side has been associated with
higher concentrations of leptin in the umbilical cord.89
● Ethnicity. Ethnic differences have also been reported,
possibly due to variable body composition in some 
specific population groups.85,90,91
Birth Weight
There is converging evidence that a strong correlation
between leptin levels and neonatal birth weight
exists,72,75,76,81,85-88 which can be a reflection of the
contribution of body fat mass in determining leptin levels.
Thus, intrauterine growth retarded (IUGR), full-term
newborns have significantly lower umbilical cord leptin
concentrations than appropriate for gestational age neonates
at birth.63,92-94 IUGR twin newborns also have lower
umbilical cord and placental leptin levels compared to their
normal size siblings.95 Later on, however, children born with
IUGR have higher serum leptin levels than children with
normal birth weight, which may indicate an adaptative leptin
resistance response which is beneficial for the catch-up
growth of these children.63 Lastly, large for gestational age
infants have higher leptin levels at birth than appropriate for
gestational age neonates, which are positively correlated with
ponderal index and umbilical cord levels of insulin.17,96-100
Prematurity 
Compared with healthy full-term babies, preterm neonates
have lower leptin levels, which are correlated to their
gestational age and birth weight,101-107 and increase after the
33rd gestational week as a reflection of respective increases of
the adipose tissue.103 Moreover, serum leptin seems to be
associated with serum insulin and the insulin/glucose ratio,
supporting the hypothesis that an ‘adipoinsular axis’ exists
and likely is functional before the 34th gestational week.108
The administration of antenatal steroids to advance embryonic
maturation has a dose-response relationship with leptin levels
at birth.108
Stress – Septicemia
An intriguing finding that needs to be confirmed is the
increase in leptin levels in neonates with bacterial septicemia,
which declines after treatment. This strengthens the role of
leptin as a stress-related hormone.109
Maternal Factors
Pathological Conditions
Pathological conditions of mothers are followed by
significant changes in leptin levels of their offspring.
Children born to mothers who developed gestational diabetes
or to mothers with type-1 diabetes mellitus have higher leptin
levels at birth compared to those of non-diabetic mothers and
are at higher risk for macrosomia.16,65,110-112 Involvement of
insulin in up-regulating leptin expression in the placenta
could be postulated as an underlying mechanism.112
Preeclampsia also influences the dynamics of leptin with
higher leptin levels reported among neonates born to mothers
with this placental insufficiency, possibly due to the
adaptative mechanisms determined by hypoxia and
subsequent stress.113-116 Likewise, leptin levels in neonates
suffering from fetal distress and hypercapnia correlate well
with pCO2.117
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Maternal Smoking During Pregnancy 
Smoking during pregnancy is known to be associated with
lower birth weight of the offspring, but the findings are
unclear with regards to the influence it exerts on leptin levels.
It has been suggested that smoking might increase the
production of catecholamines in infants and lead to lipolysis,
which might be followed by a corresponding decrease in
leptin levels.118,119 Lower leptin levels were found in some
studies,118-120 whereas no significant difference of the breast
milk leptin levels between smoking and nonsmoking women
has been reported.119,121
Maternal Nutrition and the Metabolic Status 
Maternal nutrition and metabolic status during pregnancy are
of crucial importance. A poor intrauterine milieu determined
by maternal nutritional disturbances of placental
insufficiency may alter the metabolic balance in the fetus
with severe implications in later life.1-4 Fetal programming
has been recognized as having an essential contribution in
defining the adult phenotype1,12,122 and brain development is
very sensitive to specific nutrient intake which is essential for
cell membrane formation and myelinization.123
Both maternal overfeeding and fasting during pregnancy
perturb glucose equilibrium and have been associated with risk
alterations of the offspring with regards to the development of
metabolic diseases and other pathological conditions in
adulthood. Studies with animal models found a correlation
between undernutrition throughout pregnancy and obesity,
hyperinsulinemia and hyperleptinemia,124 while malnutrition
during late gestation or in the first period of extrauterine life
resulted in lower leptin levels at the onset of puberty.125
Historical observations in humans showed that offspring of
women exposed to famine during the Dutch Hunger Winter in
their first trimester of pregnancy had increased adiposity,
while those exposed during the third trimester of pregnancy
had a significantly lower rate of obesity.126 Moreover, early
gestational famine gave rise to schizophrenia, while later
gestational famine was related to a high risk of developing
affective disorders requiring hospitalization in adulthood.127
People exposed to famine in mid and early gestation also had
a higher risk for obstructive airway disease. Therefore, it
seems that fetal lungs can be permanently affected by
nutritional challenges during periods of rapid growth.128
While the role of nutrition, regulatory hormones and other
factors in the etiology of these pathological conditions has
been established overall, it has not yet been clarified whether
leptin is an etiological factor itself or a proxy signaling the
nutritional imbalances and triggering adaptative reactions.
Apart from the quantity, the quality of diet during pregnancy
seems to play a role in defining leptin levels. Maternal
deficiency of essential fatty acids during late gestation and
lactation has been associated with decreased leptin levels of
newborns in animal studies. Thus, a link between maternal
dietary content and regulation of the amount of infant adipose
tissue and leptin mRNA expression might be present.129
Moreover, the umbilical cord concentration of fatty acids
seems to determine leptin levels in later life.130
Infant Diet
Different growth patterns in the first year of life are likely to
reflect different types of infant diets. Besides the quantitative
differences in energy, protein and micronutrients intake
between human and formula milk, there are also differences
among the growth factors contained, in terms of quality and
quantity. Because breast feeding seems to exert a protective
effect against obesity in later life,131,132 it was reasonable to
explore the relation between early life diet and leptin levels.
The evidence is contradictory. Some studies reported lower
leptin levels for breast fed infants compared to children fed
with formula milk.72,133 It is possible that formula milk may
either bring a substantial amount of leptin134 or produce some
allergic reactions that increase leptin levels.72 Other studies
found higher leptin levels among breast fed newborns and
proposed that this association was due to the acquisition of
leptin from breast milk.135-137
A correlation between leptin levels in breast milk and patterns
of perinatal growth has been suggested by some
investigations. Mothers of full-term newborns had double
leptin levels in breast milk compared to those of preterm
babies, whereas a sharp decline of leptin from colostrum to
transitional milk was evident in the former group.138 Mothers
giving birth to small for gestational age infants had reduced
leptin levels in breast milk during the first 15 days after birth
compared with appropriate for gestational age and large for
gestational age children.139 Human milk leptin concentration
beyond the neonatal period, however, seems to only correlate
well with maternal body mass index but not with the body
mass index of these infants.140,141 Thus, breast milk leptin
might have a significant role in growth, appetite and
regulation of nutrition in infancy, especially during the early
lactation period, and the production of leptin in breast tissue
might be regulated according to the needs of the infant.139
THE ROLE OF EARLY LIFE LEPTIN IN LATER LIFE
DEGENERATIVE AND CHRONIC DISEASES
The thrifty phenotype hypothesis emphasizes the importance
of early life environment in programming the susceptibility to
chronic diseases in later life.1 The programming is an
epigenetic phenomena, which means that the fetal genome
may suffer alterations to induce adaptative responses during
stressful states occurring during the critical period of
development. In support of these findings, studies with
identical twins have shown that intrauterine environmental
factors may be more important in influencing the growth and
development of the infant and differentiate the risk of disease
in later life than genetic factors. For instance, the twin with a
lower weight at birth has an increased risk of developing
diabetes mellitus and obesity in later life compared with the
other child.142
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Both children with low weight at birth and those with high
birth weight, as well as neonates suffering from IUGR (a
reflection of the consequences of different nutritional or
hormonal imbalances and of other pathological events these
children encountered during the intrauterine life), have an
increased risk of developing obesity, diabetes mellitus and
hypertension later in life.2,3,143 As indicated, leptin levels are
also altered in these children, which points to the role of this
hormone in regulating intrauterine growth and development
and defining the risk for pathology in later life.
Maternal diseases (e.g., gestational diabetes), as well as
placental insufficiency in preeclampsia and fetal pathology,
have also been associated with changes in leptin. Moreover,
the nutrition of the mother during pregnancy, along with the
diet of the infant afterwards, influences leptin levels. Breast
feeding seems to provide the newborn with an important
source of leptin, essential for adaptation during postnatal life.
It is not clear, however, how formula milk may influence the
balance of leptin and what health consequences of the changes
are induced by artificial feeding.
Leptin signals to the CNS indicates the status of energy
resources in terms of availability and promotes specific
adaptative reactions, such as setting up a low metabolic waste
regimen and influences the overall physiological intrauterine
and early life growth and development.10,12,13 Later life
degenerative outcomes seem to result from the action of
environmental factors (e.g., altered nutrition in early life) and
the subsequent metabolic and hormonal events they trigger,
and leptin is an important mediator of these reactions.
Furthermore, the association of fetal hormone levels with the
stem cell potential is an indication that human cancer, in
particular breast cancer, may have its origin in the early life
time period.7 Leptin has been studied in relation to cancer risk
and especially with those cancers related to obesity, including
breast cancer. Experimental studies have shown that leptin has
antiapoptotic effects and promotes cellular growth. However, a
direct link between leptin and carcinogenesis could not be
demonstrated in clinical studies.144
Finally, the exploration of the role of leptin as a bone
remodeling regulator and its possible involvement in neuronal
and pulmonary development is very important given the
implications for prevention.
CONCLUSIONS
Leptin is a hormone that seems to play a critical role in the
regulation of a wide spectrum of functions of organisms,
including overall metabolism, immune function, reproductive
maturation and bone formation. As indicated, leptin signals to
the CNS the availability of energy resources, is likely to trigger
adaptative reactions that influence physiological intrauterine
and early life growth and development, and appears to
contribute to infant adaptations and postnatal growth rates,
including neonatal thermogenesis and stress responses.
Birth weight is strongly related to leptin levels, whereas
maternal diseases and fetal pathology have also been
associated with short-term changes in leptin levels. The
nutrition of the mother during pregnancy, along with the diet
of the infant afterwards, also influences leptin levels.
Some factors being associated with alterations in leptin levels
have also been found to be predictive of adult disease
occurrence. Thus, it is reasonable to infer that leptin plays a
role in linking early life events and conditions with long-term
consequences. The inability to undertake longitudinal studies
from early to late life makes it difficult to directly evaluate the
existence of such associations. Nevertheless, a role of leptin
appears likely, although at this stage, it is difficult to
document whether this is a major mediating role or a
reflection of other more critical endocrine and growth-related
processes.
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